- Organized by DahShu IDSWG Oncology
- Date: Friday, May 1, 2026
- Time: 8:30am – 5:00pm Eastern Daylight Saving Time (New York)
- Lunch Break: 12:00pm – 1:00pm
- FREE but require Registration Here.
- Deadline for in-person attendees: April 17, 2026. In-person attendance will be limited to a maximum of 100 participants to accommodate venue capacity limitations and cost constraints.
- Deadline for virtual attendees: April 24, 2026.
- Dial-In information will be provided for registered participants prior to the event.
- Posters
- You are encouraged to submit posters. Poster presenter must be in-person.
- Poster Abstract: Deadline April 1st, 2026. Authors will be notified regarding poster acceptance decisions prior to the event.
- Poster Submission: Click here for poster size guidelines and to submit your poster abstract.
Objective
We are excited to announce an upcoming Key Opinion Leaders (KOL) Roundtable Discussion focused on “Biomarkers in Oncology Clinical Development.” This event brings together leading experts from academia, industry, and regulatory agencies to discuss how biomarker-driven strategies are transforming oncology drug development—from early discovery to late-phase clinical trials.
During this interactive session, panelists will explore key topics including biomarker-based patient selection, translational study design, regulatory considerations, and integration of data science and AI in biomarker discovery. Attendees will gain valuable insights into current challenges, innovative methodologies, and future directions that are shaping precision oncology.
Whether you are a clinician, statistician, data scientist, or regulatory professional, this roundtable offers a unique opportunity to learn from leaders, exchange perspectives, and network with peers driving innovation in cancer research.
Join us as we advance the conversation on leveraging biomarkers to bring safer, more effective therapies to patients faster.
Keynote Speaker
- Margaret Gamalo, PhD, FASA, Pfizer
Panelists and Speakers
- Statistics
- Jonathon Vallejo, FDA
- Liz Garrett-Mayer, ASCO
- Paul Newcombe, GSK
- Kui Shen, Bayer
- Yaji Xu, Johnson & Johnson
- Gina D’Angelo, AstraZeneca
- Heng Zhou, Merck
- David Zhang, GENMAB
- Pedro Torres-Saavedra, NCI
- Cong Chen, Merk
- AI
- Etai Jacob, AstraZeneca
- Clinical
- Jean Fan, MD, MSc. CMO, TransThera Sciences
- Antonio Tito Fojo, MD, Herbert Irving Comprehensive Cancer Center, Columbia University and James J Peters VA Medical Center
- Kaveri Suryanarayan, MD, Takeda
- Hari Sankaran, NCI
- Danielle Townsley, Amgen
- Olga Kholmanskikh, EMA
- Precision / Translational Medicine
- Ryan Hartmaier, AstraZeneca
- Hongfang Wang, Sanofi
- Mohini Rajasagi, Daiichi Sankyo
- Regulatory Affairs
- Jai Pandey, Sanofi
- Cheng Cui, AstraZeneca
Program Schedule (Tentative)
| Time (Eastern Daylight Saving Time) | Session | Title |
| 08:30AM – 09:00AM | Session 1 | Opening Remarks & Keynote |
| 09:00AM – 10:20AM | Session 2 | Biomarkers in Early Drug Development: From Target Identification to Preclinical Validation |
| 10:30AM – 12:00PM | Session 3 | Methodologies for Prognostic and Predictive Biomarker Identification and Evaluation |
| 12:00PM – 1:00PM | lunch | Poster session |
| 01:00PM – 02:20PM | Session 4 | Advanced Biomarker-Driven Clinical Trial Designs |
| 02:30PM – 03:55PM | Session 5 | Companion diagnostic (CDx) and case-studies |
| 04:05PM – 05:30PM | Session 6 | Leveraging Artificial Intelligence and Machine Learning for Biomarker Discovery and Prediction |
| 05:30PM – 05:45PM | Closing | Closing remarks |
Program Committee
- Gina D’Angelo, AstraZeneca (Chair)
- Hong Wang, Sanofi (Chair)
- Yuqian Shen, Sanofi
- Judong Shen, Merck
- Kevin Dobbin, Augusta University
- Shuguang Huang, Stat4ward
- Cindy Lu, AstraZeneca
- Xiaowen Tian, AstraZeneca
- Haijun Ma, Revolution Medicine
- Di Ran, AstraZeneca
- Sutan Wu, Daiichi Sankyo
- Philip He, Daiichi Sankyo
- Pat Mitchell, AstraZeneca
- Revathi Ananthakrishnan, BMS
- Luke Ouma, Astellas
- Jingxiao Chen, Regeneron
- Yujun Wu, Eli Lilly
- Nicole Li, BeOne Medicines
- Jun Yin, Alexion
- Yashvi Bhandari, Winston Churchill High School
- Erica (Xin) Tong, Astellas
- Heng Zhou, Merck
- Guannan Chen, GWU
- Manjari Narayan, Nyaya Labs and ML Collective
- Li Liu, Daiichi Sankyo
Location
- Sanofi conference center, 100 Morris St, Morristown, NJ 07960
Free Parking
Advance Booking Required with Sanofi Security
1. Sanofi M Station Parking Garage (Onsite):
100 Morris St, Morristown, NJ 07960
2. Sanofi Overflow Parking – Headquarters Plaza Garage (3–5 min walk):
52 Headquarters Plaza, Morristown, NJ 07960
Public Parking (approx. $10/day)
SP+ Parking: (Approximately 2-min walk to the Sanofi office and NJ Transit station)
10 Lafayette Ave, Morristown, NJ 07960
Public Transit
NJ Transit – Morristown Station:
Approximately a 5-minute walk to the Sanofi office (1-hour commute from Penn Station (NYC) or Hoboken)
Airports
- Newark Liberty International Airport (EWR) (Preferred) – ~20 miles
2. LaGuardia Airport (LGA) – ~45 miles
3. John F. Kennedy International Airport (JFK) – ~55 miles
Hotel
Hyatt Regency Morristown (9 mins walk, 3 mins drive)
Best Western Plus Morristown Inn (21 mins walk, 7 mins drive)
- 270 South St Morristown, NJ Free Breakfast. Free WiFi. Contact Us · Call +1-855-229-5934
Snack and Drink/Coffee
Light snack and drink/coffee are provided for whole day conference.
Lunch
Participants need order lunch by themselves. Options are:
– 1st Floor: Tatte (causal dining in or to-go) [same building but outside of Sanofi]
– 5th Floor: bento box to go (within Sanofi)
– 7th Floor: salad bar (within Sanofi)
Virtual Participants
The meeting link will be provided by email prior to the event.
Call for Papers: Special Collection – Oncology Precision Medicine and Biomarker Development
Please consider to submit your manuscripts to the special collection at Pharmaceutical Medicine, published by Springer Nature, with guest editors including Philip He, PhD, Daiichi Sankyo; Gina D’Angelo, AstraZeneca, PhD; Hong Wang, PhD, Sanofi; Heng Zhou, PhD, Merck; Danielle Townsley, MD, Amgen. The special collection is open to the public, regardless whether attending the event. When submit, please indicate it is for the special collection: Oncology Precision Medicine and Biomarker Development.
Pharmaceutical Medicine is a specialist discipline concerned with medical aspects of the discovery, development, evaluation, registration, regulation, monitoring, marketing, distribution and pricing of medicines, drug-device and drug-diagnostic combinations. The Journal disseminates information to support the community of professionals working in these highly inter-related functions. Key areas include translational medicine, clinical trial design, pharmacovigilance, clinical toxicology, drug regulation, clinical pharmacology, biostatistics and pharmacoeconomics. For details about its aims and scope, click here.
Sponsor
Dahshu IDSWG Oncology 